Synthesis, preliminary structure-activity relationships and biological evaluation of pyridinyl-4,5-2H-isoxazole derivatives as potent antitumor agents

被引:0
作者
Hongliang Yang
Guoxing Xu
Yazhong Pei
机构
[1] Northeast Agricultural University,College of Veterinary Medicine
[2] Jilin University,School of Pharmaceutical Sciences
来源
Chemical Research in Chinese Universities | 2017年 / 33卷
关键词
Pyridine; Isoxazole; Anticancer activity; Chemotherapeutic agent;
D O I
暂无
中图分类号
学科分类号
摘要
A series of novel pyridinyl-4,5-2H-isoxazole derivatives was synthesized and their chemical structures were characterized by 1H NMR, 13C NMR as well as MS spectroscopic methods, their melting points were also determined. The inhibitory effects of them against breast cancer cell line(MCF-7) were evaluated by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide(MTT) procedure in vitro. Most of them possesed potent anti-proliferative activities, among which 11c and 11j exhibited half maximal inhibitory concentrations(IC50) of 1.9 and 1.5 μmol/L, respectively. These compounds also exhibited potent anti-proliferative activities against both human hepatoma cell line(HepG2) and cervical cancer cell line(Hela). Preliminary Structure-activity relationship(SAR) information from these compounds can be used to guide further exploration of new compounds with better potency as molecular probes. Further study on the mechanism-of-action of these compounds is under investigation.
引用
收藏
页码:61 / 69
页数:8
相关论文
共 114 条
  • [1] Devita V. T.(2012)undefined N. Engl. J. Med. 366 2207-undefined
  • [2] Rosenberg S. A.(1995)undefined Ann. Surg. 221 327-undefined
  • [3] Daly J. M.(2012)undefined Cancer Res. 115 221-undefined
  • [4] Weintraub F. N.(2013)undefined J. Clin. Oncol. 31 1009-undefined
  • [5] Shou J.(2011)undefined J. Nanjing Univ. Tradit. Chin. Med. 1 4-undefined
  • [6] Rosato E. F.(2006)undefined Clin. Cancer Res. 12 2366-undefined
  • [7] Lucia M.(2008)undefined Adv. Mater. 20 478-undefined
  • [8] Kaliberov S. A.(2008)undefined Drug Future 33 969-undefined
  • [9] Buchsbaum D. J.(2007)undefined Ann. Oncol. 18 581-undefined
  • [10] Gerber D. E.(2011)undefined Talanta 85 2265-undefined